Status:
COMPLETED
Enhanced Adherence Counselling, Pre-Post Study
Lead Sponsor:
Elizabeth Glaser Pediatric AIDS Foundation
Collaborating Sponsors:
Centers for Disease Control and Prevention
Conditions:
HIV Infection
Eligibility:
All Genders
Up to 19 years
Phase:
NA
Brief Summary
Viral suppression among children and adolescents in Kenya is currently sub-optimal at 60% and 63% respectively. Under the current Kenya Ministry of Health Guidelines, clients with viral load of \>1000...
Detailed Description
BACKGROUND Viral suppression is a proxy for successful anti-retroviral therapy (ART) and is the "3rd 90" of the (Joint United Nations Programme on HIV/AIDS (UNAIDS) 90-90-90 strategy. In Kenya, viral ...
Eligibility Criteria
Inclusion
- Inclusion Criteria for children and adolescents
- Age 0-19 years
- HIV positive
- On ART for at least 6 months
- Last VL \>1000 copies
- Parental/guardian consent
- Assent (for 10-17-year old)
- Consent (for 18-19-year old)
- Inclusion criteria for parents/caregivers
- Parent/guardian to a child/adolescent on ART with VL\>1000 copies
- Provides consent
- Inclusion criteria for service providers, Peer educators, Adherence/Psychosocial support counselors
- Working in the facility for at least 3 months
- Provides services to HIV positive children and adolescents on ART
- Provides consent
- Exclusion Criteria:
- Already receiving EAC
- Receiving services at non-participating facility
- Not providing HIV services to children and adolescent
Exclusion
Key Trial Info
Start Date :
March 4 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 20 2020
Estimated Enrollment :
741 Patients enrolled
Trial Details
Trial ID
NCT04915469
Start Date
March 4 2019
End Date
September 20 2020
Last Update
June 7 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Homa Bay county
Homa Bay, Kenya